Skip to main content

Ciprofloxacin in the Treatment of Infections Caused by Gentamicin-Resistant Gram-Negative Bacteria

  • Chapter
Book cover Ciprofloxacin

Part of the book series: Current Topics in Infectious Diseases and Clinical Microbiology ((CTIDCM,volume 1))

  • 62 Accesses

Abstract

Ciprofloxacin is a new synthetic 4-quinolone with marked antibacterial activity against a wide spectrum of aerobic gram-negative bacteria (1). In view of its in vitro activity ciprofloxacin shows great potential as an antibiotic for oral treatment of infections caused by resistant gram-negative organisms (2). The lack of cross-resistance with other groups of agents such as beta-lactam antibiotics and aminoglycosides is advantageous particularly since no plasmid-mediated resistance has been found (3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. King, A., Shannon, K., Phillips, I.: The in vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin. Journal of Antimicrobial Chemotherapy 1985, 15: 551–558.

    Article  PubMed  CAS  Google Scholar 

  2. Palton, W. N., Smith, G. N., Leyland, M. J., Geddes, A. M.: Multiply resistant Salmonella typhimurium septicaemia in an immunocompromised patient successfully treated with ciprofloxacin. Journal of Antimicrobial Chemotherapy 1985, 16: 667–669.

    Article  Google Scholar 

  3. Smith, J. T.: Mutational resistance to 4-quinolone antibacterial agents. European Journal of Clinical Microbiology 1984, 3: 347–350.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

H. C. Neu D. S. Reeves

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer Fachmedien Wiesbaden

About this chapter

Cite this chapter

Mehtar, S., Drabu, Y., Blakemore, P. (1986). Ciprofloxacin in the Treatment of Infections Caused by Gentamicin-Resistant Gram-Negative Bacteria. In: Neu, H.C., Reeves, D.S. (eds) Ciprofloxacin. Current Topics in Infectious Diseases and Clinical Microbiology, vol 1. Vieweg+Teubner Verlag, Wiesbaden. https://doi.org/10.1007/978-3-663-01930-5_35

Download citation

  • DOI: https://doi.org/10.1007/978-3-663-01930-5_35

  • Publisher Name: Vieweg+Teubner Verlag, Wiesbaden

  • Print ISBN: 978-3-663-01931-2

  • Online ISBN: 978-3-663-01930-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics